8-K filing — MESA LABORATORIES INC /CO/ (MLAB)
Filed: 2026-10-13 AccNo: 0001437749-26-032499 Size: 184 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Mesa Laboratories Plans Restructuring Program To Cut Annual Operating Costs By ~$9.3M; Expects Pre-Tax Charges Of ~$2.6M - $3.4M In H2 FY27; Saving Plan To Be Fully Reflected In Annualized Cost Structure By End Of FY28
Mesa Laboratories, Inc. (NASDAQ: MLAB) ("Mesa," "we," "us" or "our"), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110
Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $94 to $110.
Mesa Laboratories shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.